These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 21415133)

  • 1. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection.
    Viasus D; Paño-Pardo JR; Pachón J; Riera M; López-Medrano F; Payeras A; Fariñas MC; Moreno A; Rodríguez-Baño J; Oteo JA; Ortega L; Torre-Cisneros J; Segura F; Carratalà J;
    Chest; 2011 Oct; 140(4):1025-1032. PubMed ID: 21415133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study.
    Hiba V; Chowers M; Levi-Vinograd I; Rubinovitch B; Leibovici L; Paul M
    J Antimicrob Chemother; 2011 May; 66(5):1150-5. PubMed ID: 21393197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in HIV-infected patients admitted due to pandemic influenza.
    López-Aldeguer J; Iribarren JA; Valencia E; Barquilla E; Knobel H; Santos J; Lozano F;
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):608-12. PubMed ID: 22459686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
    Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
    N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rising Oseltamivir Use Among Hospitalized Children in a Postpandemic Era.
    Williams JT; Cunningham MA; Wilson KM; Rao S
    Hosp Pediatr; 2016 Mar; 6(3):172-8. PubMed ID: 26908818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pandemic (H1N1) 2009 influenza in hospitalized children in Manitoba: nosocomial transmission and lessons learned from the first wave.
    Fanella ST; Pinto MA; Bridger NA; Bullard JM; Coombs JM; Crockett ME; Olekson KL; Poliquin PG; Van Caeseele PG; Embree JE
    Infect Control Hosp Epidemiol; 2011 May; 32(5):435-43. PubMed ID: 21515973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical effectiveness of oseltamivir in mild cases of pandemic influenza A H1N1 2009 infection.
    Lee JS; Park SY; Kim JS; You JY; Ju YS; Eom JS
    Scand J Infect Dis; 2012 Aug; 44(8):595-9. PubMed ID: 22497285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
    Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
    Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.
    Kim WY; Young Suh G; Huh JW; Kim SH; Kim MJ; Kim YS; Kim HR; Ryu YJ; Han MS; Ko YG; Chon GR; Lee KH; Choi SH; Hong SB;
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5703-9. PubMed ID: 21968371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Influenza A H1N1 infection and antiviral utilization in a tertiary care hospital.
    Belucci TR; Marra AR; Edmond MB; Pinho JRR; Yokota PKO; Mafra ACCN; Dos Santos OFP
    BMC Infect Dis; 2018 Nov; 18(1):579. PubMed ID: 30445924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain.
    Canadell L; Martín-Loeches I; Díaz E; Trefler S; Grau S; Yebenes JC; Almirall J; Olona M; Sureda F; Blanquer J; Rodriguez A;
    Med Intensiva; 2015 May; 39(4):222-33. PubMed ID: 25107582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
    Yu H; Liao Q; Yuan Y; Zhou L; Xiang N; Huai Y; Guo X; Zheng Y; van Doorn HR; Farrar J; Gao Z; Feng Z; Wang Y; Yang W
    BMJ; 2010 Sep; 341():c4779. PubMed ID: 20876641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcome of patients with pandemic 2009 Influenza A(H1N1)v virus infection admitted to hospitals with different levels of health-care.
    Gutiérrez-Cuadra M; González-Fernández JL; Rodríguez-Cundin P; Fariñas-Álvarez C; San Juan MV; Parra JA; Carrascosa M; Fariñas MC
    Rev Esp Quimioter; 2012 Mar; 25(1):56-64. PubMed ID: 22488543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.
    Reid G; Huprikar S; Patel G; Razonable RR; Mossad S; Levi M; Gregg K; Shoham S; Humar A; Adams W; Kumar D
    Transpl Infect Dis; 2013 Oct; 15(5):487-92. PubMed ID: 23890293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.
    Higuera Iglesias AL; Kudo K; Manabe T; Corcho Berdugo AE; Corrales Baeza A; Alfaro Ramos L; Guevara Gutiérrez R; Manjarrez Zavala ME; Takasaki J; Izumi S; Bautista E; Perez Padilla JR
    PLoS One; 2011; 6(7):e21838. PubMed ID: 21760915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic influenza H1N1 2009 virus infection in pregnancy in Turkey.
    Ozyer S; Unlü S; Celen S; Uzunlar O; Saygan S; Su FA; Beşli M; Danışman N; Mollamahmutoğlu L
    Taiwan J Obstet Gynecol; 2011 Sep; 50(3):312-7. PubMed ID: 22030045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.
    Kanchana S; Kanchana S; Chuntrakul C; Malathum K; Prachayangprecha S; Poovorawan Y
    J Infect; 2011 Oct; 63(4):295-9. PubMed ID: 21840339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
    Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
    Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of 2009 A(H1N1) influenza in hospitalized pregnant women in a context of early diagnosis and antiviral therapy.
    Paño-Pardo JR; Rodríguez-Baño J; Martínez-Sánchez N; Viasus D; Fariñas MC; Leyes M; López-Medrano F; Pachón J; Torre-Cisneros J; Oteo JA; Pumarola T; García-Gasalla M; Ortega L; Segura F; Carratalá J;
    Antivir Ther; 2012; 17(4):719-28. PubMed ID: 22301005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.